UNSPSC 51286601: Efrotomycin

This classification denotes an antibiotic with the molecular formula C59H88N2O20, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5BPJ82Q45X, chemically known as mocimycin, 31-o-(6-deoxy-4-o-(6-deoxy-2,4-di-o-methyl-alpha-l-mannopyranosyl)-3-o-methyl-beta-d-allopyranosyl)-1-methyl- but more generally known as efrotomycin, which bears US NIH Compound Identifier 6436033. European Medicines Agency schedules Efrotomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06472MIG.

UNSPSC 51286601 Efrotomycin is a Commodity code, but the recent state and local solicitations tagged under it actually concern naloxone, pharmaceutical products, and medical supplies — not efrotomycin specifically. The code shows a mismatch between its nominal scope and the work being procured. State and local governments soliciting under this code are acquiring naloxone (opioid antagonist), generic pharmaceuticals, over-the-counter products, and related medical supplies for public health, emergency response, and employee health programs. Issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas Health and Human Services Commission), municipal fire departments (City of Tampa Fire Department Rescue Division), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving state and local participants across multiple states including Oregon). The procurement mix spans both direct pharmaceutical manufacturing relationships and supply-chain delivery through authorized wholesalers, reflecting ongoing state and local interest in cost management and direct-to-manufacturer contracting models alongside traditional bid-based medical supply procurement.

Recent activity appears concentrated in Florida, Texas, and Minnesota. A Seminole County IFB (Solicitation IFB60459723LAS, due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The City of Tampa issued an IFB (26P00145, due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a five percent bid discount for certified Small Local Business Enterprises. The Texas Health and Human Services Commission issued a Request for Information (HHS0017013, due April 3, 2026) to gather vendor capabilities on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels. MMCAP, administered by the Minnesota Department of Administration, issued an RFP (S1070000015802, due March 26, 2026) for multiple contracts covering generic pharmaceuticals and OTC products distributed across state and local facilities, with products required in the marketplace by May 15, 2026 and contract effectiveness July 1, 2026. Set-asides and preferences vary by issuing body — Tampa designated its procurement as a sheltered market for certified Small Local Business Enterprises, while MMCAP did not identify specific disadvantaged-enterprise restrictions in available documentation.